| pubmed-article:1320450 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1320450 | lifeskim:mentions | umls-concept:C0086045 | lld:lifeskim |
| pubmed-article:1320450 | lifeskim:mentions | umls-concept:C1512505 | lld:lifeskim |
| pubmed-article:1320450 | lifeskim:mentions | umls-concept:C0030956 | lld:lifeskim |
| pubmed-article:1320450 | lifeskim:mentions | umls-concept:C0035031 | lld:lifeskim |
| pubmed-article:1320450 | lifeskim:mentions | umls-concept:C0441472 | lld:lifeskim |
| pubmed-article:1320450 | lifeskim:mentions | umls-concept:C0018270 | lld:lifeskim |
| pubmed-article:1320450 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:1320450 | pubmed:dateCreated | 1992-8-7 | lld:pubmed |
| pubmed-article:1320450 | pubmed:abstractText | The effects of relaxin (RLX) on the human breast adenocarcinoma cell line MCF-7 have been evaluated. | lld:pubmed |
| pubmed-article:1320450 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1320450 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1320450 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:1320450 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1320450 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1320450 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1320450 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:1320450 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:1320450 | pubmed:author | pubmed-author:BaniGG | lld:pubmed |
| pubmed-article:1320450 | pubmed:author | pubmed-author:SacchiT BTB | lld:pubmed |
| pubmed-article:1320450 | pubmed:author | pubmed-author:BigazziMM | lld:pubmed |
| pubmed-article:1320450 | pubmed:author | pubmed-author:BrandiM LML | lld:pubmed |
| pubmed-article:1320450 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1320450 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:1320450 | pubmed:volume | 70 | lld:pubmed |
| pubmed-article:1320450 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1320450 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1320450 | pubmed:pagination | 639-43 | lld:pubmed |
| pubmed-article:1320450 | pubmed:dateRevised | 2010-3-24 | lld:pubmed |
| pubmed-article:1320450 | pubmed:meshHeading | pubmed-meshheading:1320450-... | lld:pubmed |
| pubmed-article:1320450 | pubmed:meshHeading | pubmed-meshheading:1320450-... | lld:pubmed |
| pubmed-article:1320450 | pubmed:meshHeading | pubmed-meshheading:1320450-... | lld:pubmed |
| pubmed-article:1320450 | pubmed:meshHeading | pubmed-meshheading:1320450-... | lld:pubmed |
| pubmed-article:1320450 | pubmed:meshHeading | pubmed-meshheading:1320450-... | lld:pubmed |
| pubmed-article:1320450 | pubmed:meshHeading | pubmed-meshheading:1320450-... | lld:pubmed |
| pubmed-article:1320450 | pubmed:meshHeading | pubmed-meshheading:1320450-... | lld:pubmed |
| pubmed-article:1320450 | pubmed:meshHeading | pubmed-meshheading:1320450-... | lld:pubmed |
| pubmed-article:1320450 | pubmed:meshHeading | pubmed-meshheading:1320450-... | lld:pubmed |
| pubmed-article:1320450 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1320450 | pubmed:articleTitle | Relaxin influences the growth of MCF-7 breast cancer cells. Mitogenic and antimitogenic action depends on peptide concentration. | lld:pubmed |
| pubmed-article:1320450 | pubmed:affiliation | Prosperius Institute, RIA Section, Florence, Italy. | lld:pubmed |
| pubmed-article:1320450 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1320450 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1320450 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1320450 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1320450 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1320450 | lld:pubmed |
